GIBRALT Trademark

Trademark Overview


On Wednesday, August 14, 2019, a trademark application was filed for GIBRALT with the United States Patent and Trademark Office. The USPTO has given the GIBRALT trademark a serial number of 88578157. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, June 8, 2020. This trademark is owned by Pfizer Inc.. The GIBRALT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
gibralt

General Information


Serial Number88578157
Word MarkGIBRALT
Filing DateWednesday, August 14, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, June 8, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 7, 2020ASSIGNED TO LIE
Monday, May 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 4, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, May 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 25, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 25, 2019NON-FINAL ACTION E-MAILED
Monday, November 25, 2019NON-FINAL ACTION WRITTEN
Thursday, November 14, 2019ASSIGNED TO EXAMINER
Thursday, August 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 17, 2019NEW APPLICATION ENTERED IN TRAM